# Ultralow Dose PAH Binary Mixture Study

> **NCT03631667** · EARLY_PHASE1 · COMPLETED · sponsor: **Oregon State University** · enrollment: 8 (actual)

## Conditions studied

- Environmental Exposure

## Interventions

- **DRUG:** [14C]-benzo[a]pyrene
- **DRUG:** [14C]-benzo[a]pyrene plus phenanthrene

## Key facts

- **NCT ID:** NCT03631667
- **Lead sponsor:** Oregon State University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-01
- **Primary completion:** 2024-01-01
- **Final completion:** 2024-02-01
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2025-05-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03631667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03631667, "Ultralow Dose PAH Binary Mixture Study". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03631667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*